PACAP
Alternative Names: PACAP 1-27; PACAP 1-38; PACAP 6-38; PACAP-27; PACAP-38; Pituitary adenylate cyclase activating polypeptideLatest Information Update: 25 Sep 2021
Price :
$50 *
At a glance
- Originator Tulane University
- Class Muscle relaxants; Neuropeptides; Peptides; Vasodilators
- Mechanism of Action Adenylate cyclase inhibitors; Adenylate cyclase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma; Neurological disorders; Non-small cell lung cancer; Stroke
Most Recent Events
- 19 Sep 2003 Discontinued - Phase-I for Asthma in Europe (unspecified route)
- 19 Sep 2003 Discontinued - Phase-I for Neurological disorders in Europe (unspecified route)
- 19 Sep 2003 Discontinued - Phase-I for Stroke in Europe (unspecified route)